Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1

被引:87
|
作者
Desclozeaux, M
Krylova, IN
Horn, F
Fletterick, RJ
Ingraham, HA
机构
[1] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Mol Pharmacol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
关键词
D O I
10.1128/MCB.22.20.7193-7203.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroidogenic factor 1 (SF-1) is an orphan nuclear receptor with no known ligand. We showed previously that phosphorylation at serine 203 located N'-terminal to the ligand binding domain (LBD) enhanced cofactor recruitment, analogous to the ligand-mediated recruitment in ligand-dependent receptors. In this study, results of biochemical analyses and an LBD helix assembly assay suggest that the SF-1 LBD adopts an active conformation, with helices 1 and 12 packed against the predicted alpha-helical bundle, in the apparent absence of ligand. Fine mapping of the previously defined proximal activation function in SF-1 showed that the activation function mapped fully to helix 1 of the LBD. Limited proteolyses demonstrate that phosphorylation of S203 in the hinge region mimics the stabilizing effects of ligand on the LBD. Moreover, similar effect,, were observed in an SF-1/thyroid hormone LBD chimera receptor, illustrating that the S203 phosphorylation effects are transferable to a heterologous ligand-dependent receptor. Our collective data suggest that the hinge together with helix I is an individualized specific motif, which is tightly associated with its cognate LBD. For SF-1, we find that this intramolecular association and hence receptor activity are further enhanced by mitogen-activated protein kinase phosphorylation, thus mimicking many of the ligand-induced changes observed for ligand-dependent receptors.
引用
收藏
页码:7193 / 7203
页数:11
相关论文
共 50 条
  • [1] Characterization of the ligand binding domain of steroidogenic factor-1
    Urs, A
    Merrill, AH
    FASEB JOURNAL, 2005, 19 (04): : A840 - A840
  • [2] Polymorphism of the Epidermal Growth Factor Receptor Extracellular Ligand Binding Domain: The Dimer Interface Depends on Domain Stabilization
    Zhang, Zhiyong
    Wriggers, Willy
    BIOCHEMISTRY, 2011, 50 (12) : 2144 - 2156
  • [3] 25-hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1)
    Mellon, SH
    Bair, SR
    ENDOCRINOLOGY, 1998, 139 (06) : 3026 - 3029
  • [4] Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding
    Pissios, P
    Tzameli, I
    Kushner, P
    Moore, DD
    MOLECULAR CELL, 2000, 6 (02) : 245 - 253
  • [5] Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols
    Lala, DS
    Syka, PM
    Lazarchik, SB
    Mangelsdorf, DJ
    Parker, KL
    Heyman, RA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 4895 - 4900
  • [6] The nuclear receptor ligand-binding domain: structure and function
    Moras, D
    Gronemeyer, H
    CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (03) : 384 - 391
  • [7] Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage
    Crawford, PA
    Sadovsky, Y
    Milbrandt, J
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) : 3997 - 4006
  • [8] Function of steroidogenic factor 1 (SF1) ligand-binding domain in gene activation and interaction with AP1
    Li, LA
    Lala, D
    Chung, BC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) : 318 - 320
  • [9] Temporal analysis of steroidogenic factor-1 binding to the human CYP17 promoter: Roles of ligand binding, coactivator recruitment, and phosphorylation
    Dammer, E
    Leon, A
    Sewer, MB
    FASEB JOURNAL, 2006, 20 (05): : A969 - A969
  • [10] A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency
    Correa, RV
    Domenice, S
    Bingham, NC
    Billerbeck, AEC
    Rainey, WE
    Parker, KL
    Mendonca, BB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04): : 1767 - 1772